期刊文献+

丝裂霉素和卡介苗素膀胱内灌注预防膀胱癌术后复发的疗效观察 被引量:5

Prevention of recurrence of bladder cancer by intravesical instillation with combination of Mitomycin C and Bacillus Calmette_Guerir after TURBt
下载PDF
导出
摘要 目的 探讨提高膀胱癌的治疗效果 ,降低术后复发率的更佳膀胱内灌注方案。方法 将42例行经尿道膀胱肿瘤电切术 (TURBt)的浅表性膀胱癌分为两组 :A组 (21例 )膀胱内灌注丝裂霉素加卡介苗素 ,B组 (21例 )膀胱内单纯灌注丝裂霉素。两组均在术后1周内开始灌注 ,每周1次 ,共6次 ,然后每月1次 ,共2年。 结果 随访12~28个月 ,A组复发1例 ,复发率4.8% ,B组复发7例 ,复发率33.3% ,两组复发率的并别有显著性意义 (P<0.05)。 结论 Objective To improve the effect of intravesical instillation treatment and reduce the postoperation recurrence rate of bladder cancer.Methods Forty two patients with bladder cancer after TURBt were divided into two groups to receive intravesical instillation treatment with combination of Mitomycin C and Bacillus Calmette_Guerir(BCG) or Mitomycin C alone respectively after operation.Results All these patients were following up from 12 to 28 months.Recurrence rate in the group treated with combination of Mitomycin and BCG was 4.8%(1/21) and 3.3%(7/21) in the group treated with Mitomycin C alone(P<0.085).Conclusion Intravesical instillation with Mitomycin C combination with BCG may be the more effective therapy in prevention of recurrence after TURBt.
出处 《浙江医学》 CAS 2002年第6期328-329,共2页 Zhejiang Medical Journal
关键词 丝裂霉素 卡介苗素 膀胱内灌注 预防 膀胱癌 术后复发 疗效观察 Bladder tumor Mitomycin C Bacillus calmette_Guerir
  • 相关文献

参考文献6

二级参考文献14

  • 1李家贵,徐文超,张旭.卡介苗对体外培养膀胱癌细胞株的直接作用和形态学观察[J].中华实验外科杂志,1994,11(3):184-185. 被引量:1
  • 2杨江根,中华泌尿外科杂志,1990年,11卷,202页
  • 3孙帮华,中国免疫学杂志,1988年,1卷,50页
  • 4侯云德,干扰素及其临床应用,1981年
  • 5黄胜源,广东医学,1992年,13卷,252页
  • 6袁孔华,中华泌尿外科杂志,1992年,13卷,276页
  • 7孟荟,中华泌尿外科杂志,1986年,7卷,32页
  • 8GlesbersAM,VanHelsdingonPO,KramerAL.Recurrenceofsuperficralbladdercarcinomaoftermtravesicalmstilldtionofmitomycine-ccomprisenofexposuretime.BrJUrol,1989,63:176~181
  • 9EI-DemiryMIM,SmithG,RichieAWS.LocalimmunoresponsesoftermcravesicalBCGtreutmeutoflarcinomainsitu.BrJUrol,1987,60:543~547
  • 10T. M. Reijke,P. C. N. Vos,E. C. Boer,R. F. M. Bevers,W. H. Muinck Keizer,K. H. Kurth,D. H. J. Schamhart. Cytokine production by the human bladder carcinoma cell line T24 in the presence of bacillus Calmette-Guerin (BCG)[J] 1993,Urological Research(5):349~352

共引文献45

同被引文献52

  • 1朱捷,徐阿祥,洪宝发,叶林阳,张磊,王晓雄.两种膀胱灌注疗法影响浅表性膀胱癌术后患者生活质量和复发等预后因素的比较[J].中国临床康复,2005,9(22):152-154. 被引量:2
  • 2张杰敏,阮萍,谢庆环,邢立花,卢金凤.膀胱灌注药物预防膀胱癌术后复发的护理[J].护理研究(下旬版),2005,19(9):1955-1956. 被引量:8
  • 3兰卫华,靳风烁,王洛夫,张军,孙中义,谢芳.卡介苗与丝裂霉素C膀胱灌注预防国人膀胱癌复发的比较的Meta分析[J].临床泌尿外科杂志,2006,21(2):145-148. 被引量:10
  • 4周四维,杨为民,叶章群,赵建军.卡介苗膀胱灌注的并发症及其防治(附9例报告)[J].临床泌尿外科杂志,1996,11(1):3-5. 被引量:9
  • 5Bohle A, Balck F, Von Wietersheim J, et al. The quality of life during intravesical bacillus Calmette-Guerin therapy [J]. J Urol, 1996, 155(4) :1221-1226.
  • 6杨士保,孙振球.Meta分析.方积乾,主编.卫生统计学.第5版.北京:人民卫生出版社,2003.399-416.
  • 7Reijke TM,Kurth KH,Sylvester RJ,et al.Bacillus Calmette-Guerin versus epirubicin for primary,secondary or concurrent carcinoma in situ of the bladder:results of a European Organization for the Research and Treatment of Cancer-Genito-Urinary Group Phase Ⅲ Trial.J Urol,2005,173:405-409.
  • 8Di Stasi SM,Giannantoni A,Stephen RL,et al.Intravesical electromotive mitomycin C versus passive transport mitomycin C for high risk superficial bladder cancer:a prospective randomized study.J Urol,2003,170:777-782.
  • 9Kaasinen E,Wijkstrom H,Malmstrom PU,et al.Alternating mitomycin C and BCG instillations versus BCG alone in treatment of carcinoma in situ of the urinary bladder:a nordic study.Eur Urol,2003,43:637-645.
  • 10Tozawa K,Okamura T,Sasaki S,et al.Intravesical combined chemoimmunotherapy with epirubicin and bacillus Calmette-Guerin is not indicated for superficial bladder cancer.Urol Int,2001,67:289-292.

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部